Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Neuroscience Center actively treats complex and treatment-resistant neuropsychiatric conditions with a portfolio of advanced therapies including FDA-approved drugs (e.g., esketamine), established device-based modalities (rTMS, HBOT), and personalized treatment strategies. They report high success in cases unresponsive to standard treatments but do not disclose formal clinical trial data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Neuroscience Center.